| Dr Amber Hiergesell Moss, OD | |
|
59 Woodruff Industrial Ln, Suite A, Greenville, SC 29607-4147 | |
| (864) 289-0000 | |
| (864) 289-0001 |
| Full Name | Dr Amber Hiergesell Moss |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 15 Years |
| Location | 59 Woodruff Industrial Ln, Greenville, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093049298 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1573 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr Mcgregor And Associates Pa | 1557275518 | 5 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended September 30, 2010.
A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
› Verified 9 days ago
| Provider Name | Dr Mcgregor And Associates Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043228851 PECOS PAC ID: 1557275518 Enrollment ID: O20031114000367 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended September 30, 2010.
A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
› Verified 9 days ago
| Provider Name | Family Vision Of Anderson Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629121165 PECOS PAC ID: 8224303227 Enrollment ID: O20171002000132 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended September 30, 2010.
A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amber Hiergesell Moss, OD 59 Woodruff Industrial Ln, Suite A, Greenville, SC 29607-4147 Ph: (864) 289-0000 | Dr Amber Hiergesell Moss, OD 59 Woodruff Industrial Ln, Suite A, Greenville, SC 29607-4147 Ph: (864) 289-0000 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended September 30, 2010.
A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.
Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.
› Verified 9 days ago
One Way Eyeglasses Optometrist Medicare: Not Enrolled in Medicare Practice Location: 50 E Antrim Dr, Greenville, SC 29607 Phone: 864-235-8778 Fax: 864-235-8783 | |
Dr. Nichole Haberkorn, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 101 Verdae Blvd Ste 160, Greenville, SC 29607 Phone: 864-676-1123 Fax: 864-675-3835 | |
Eye Care Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3529 Highway 153, Greenville, SC 29611 Phone: 864-295-3550 Fax: 864-295-3242 | |
Dr. Scott Mogavero, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 41 Park Creek Dr, Greenville, SC 29605 Phone: 864-299-1600 | |
Dr. Mcgregor And Associates Pa Optometrist Medicare: Medicare Enrolled Practice Location: 1609 Woodruff Rd, Greenville, SC 29607 Phone: 864-288-7445 Fax: 864-288-8288 | |
Dr. David Martin Nigh, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 765 Haywood Rd Suite B1, Greenville, SC 29607 Phone: 864-234-5777 |